These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 1095296)

  • 1. Leydig cells.
    Neaves WB
    Contraception; 1975 May; 11(5):571-606. PubMed ID: 1095296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of pharmaceutical compounds on male fertility.
    Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
    Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF; Rollet J
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous antispermatogenic agents: prospects for male contraception.
    Ewing LL; Robaire B
    Annu Rev Pharmacol Toxicol; 1978; 18():167-87. PubMed ID: 206192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in the control of testicular function.
    Swerdloff RS; Wang C; Bhasin S
    Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro steroid metabolic studies in human testes I: Effects of estrogen on progesterone metabolism.
    Rodriguez-Rigau LJ; Tcholakian RK; Smith KD; Steinberger E
    Steroids; 1977 Jun; 29(6):771-86. PubMed ID: 910250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and hormonal target cells in the testis.
    Hansson V; Djoseland O; Torgersen O; Ritzen EM; French FS; Nayfeh SN
    Andrologia; 1976; 8(3):195-202. PubMed ID: 187086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives.
    Johnson L; Barnard JJ; Rodriguez L; Smith EC; Swerdloff RS; Wang XH; Wang C
    J Androl; 1998; 19(3):348-57. PubMed ID: 9639052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germinal cell aplasia: response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone to LH/FSH-releasing hormone with histopathologic correlation.
    Guay AT; Tuthill RJ; Woolf PD
    Fertil Steril; 1977 Jun; 28(6):642-9. PubMed ID: 324822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
    Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
    Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration effects of exogenous luteinizing hormone on the testicular steroidogenesis and Leydig cell ultrastructure.
    Wing TY; Ewing LL; Zegeye B; Zirkin BR
    Endocrinology; 1985 Nov; 117(5):1779-87. PubMed ID: 4042963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of selective withdrawal of FSH or LH on spermatogenesis in the immature rat.
    Madhwa Raj HG; Dym M
    Biol Reprod; 1976 May; 14(4):489-94. PubMed ID: 819047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target sites for suppressing fertility in the male.
    Prasad MR; Rajalakshmi M
    Adv Sex Horm Res; 1976; 2():263-87. PubMed ID: 797248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
    Moltz L; Römmler A; Post K; Schwartz U; Hammerstein J
    Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.